Lakefront Biotherapeutics (GLPGF) Exchange Rate Effect (2016 - 2026)
Lakefront Biotherapeutics' (GLPGF) quarterly Exchange Rate Effect came in at $819522.0 in Q1 2026, up 159.98% year-over-year from $315228.9 in Q1 2025, and up 152.27% quarter-over-quarter from -$1.6 million in Q4 2025.
Analysis
Lakefront Biotherapeutics (GLPGF) Exchange Rate Effect (2016 - 2026) Analysis & Trends
Lakefront Biotherapeutics (GLPGF) has reported Exchange Rate Effect for 11 consecutive years, with $819522.0 the latest figure, recorded in Q1 2026.
- On a quarterly basis, Exchange Rate Effect rose 159.98% year-over-year to $819522.0 in Q1 2026; TTM through Mar 2026 was -$2.8 million, a 45519.78% decrease from a year earlier, with the FY2025 full-year figure at -$5.0 million, down 361.02% from the prior year.
- Exchange Rate Effect was $819522.0 for Q1 2026 at Lakefront Biotherapeutics, up from -$1.6 million in the prior quarter.
- Over five years, Exchange Rate Effect peaked at $18.4 million in Q1 2022 and troughed at -$3.8 million in Q4 2022.
- A 5-year average of $798144.7 and a median of -$272628.8 in 2023 frame the typical range for Exchange Rate Effect.
- Across the five-year window, Exchange Rate Effect surged 298.84% in 2024 and plunged 511.86% in 2025, its largest moves.
- Over 5 years, Exchange Rate Effect stood at -$3.8 million in 2022, then surged by 57.0% to -$1.6 million in 2023, then surged by 186.72% to $1.4 million in 2024, then tumbled by 210.41% to -$1.6 million in 2025, then soared by 152.27% to $819522.0 in 2026.
- The last three Exchange Rate Effect figures came in at $819522.0 (Q1 2026), -$1.6 million (Q4 2025), and -$100538.7 (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Exchange Rate Effect (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.51 Bn | 197.52 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 181.48 Bn | 178.30 Bn | 6.22 Bn | -19.00 Mn |
| 3 | Vertex Pharmaceuticals | 132.45 Bn | 124.60 Bn | 2.84 Bn | -3.70 Mn |
| 4 | Regeneron Pharmaceuticals | 82.87 Bn | 74.88 Bn | 3.93 Bn | -300,000.00 |
| 5 | Argenx Se | 61.59 Bn | 56.41 Bn | 1.37 Bn | - |
| 6 | Moderna | 54.72 Bn | 49.59 Bn | 52.00 Mn | -2.00 Mn |
| 7 | Alnylam Pharmaceuticals | 34.13 Bn | 30.82 Bn | 992.69 Mn | -2.45 Mn |
| 8 | Biogen | 31.29 Bn | 30.01 Bn | 1.96 Bn | -3.40 Mn |
| 9 | Roivant Sciences | 30.31 Bn | 30.31 Bn | 1.16 Mn | 315,000.00 |
| 10 | Lakefront Biotherapeutics | 1.73 Bn | 1.73 Bn | 3.51 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | 819,521.96 |
| Dec 31, 2025 | -1.57 Mn |
| Sep 30, 2025 | -100,538.74 |
| Jun 30, 2025 | -1.95 Mn |
| Mar 31, 2025 | -1.37 Mn |
| Dec 31, 2024 | 1.42 Mn |
| Sep 30, 2024 | -533,734.68 |
| Jun 30, 2024 | 473,830.53 |
| Mar 31, 2024 | 542,094.52 |
| Dec 31, 2023 | -1.64 Mn |
| Mar 31, 2023 | -272,628.82 |
| Dec 31, 2022 | -3.81 Mn |
| Mar 31, 2022 | 18.36 Mn |
| Jun 30, 2021 | -11.60 Mn |
| Mar 31, 2021 | 38.30 Mn |
| Dec 31, 2020 | -84.10 Mn |
| Dec 31, 2019 | -11.03 Mn |
| Jun 30, 2019 | -3.49 Mn |
| Mar 31, 2019 | 5.65 Mn |
| Dec 31, 2018 | 11.51 Bn |